Reply To: Recently read of a promising study using a vitamin d analog, calcipitriol, for pancreatic cancer. What can you tell me about calcipitriol and can the general public utilize it as a supplement.
the article, written by mara H sherman in CELL just 5 months ago, clearly stated that the benefit was only seen with vitamin D analoogues. specifically Calcipitriol. As a family member of someone diagnosed with pancreatic cancer, I am understandably very interested in this finding. Problem being, all analogues need a prescription, and doctors are unwilling to step outside their “safe zone” when asked about it. There seems to be a variance on the article, one stating calcipitriol (commonly prescribed as a cream for psoriasis) and others referring to paricalcitol, a drug used for reducing parathyroid hormone. Obviously, this issue will be pushed with the treating oncologist, however given that the end result of using either of these analogues is increased vitamin D, Its very difficult to sit idle knowing that such a promising variant of vitamin D is available but unnatainable. The full, unlocked research can be found here:http://www.housemajority.org/wp-content/uploads/2014/10/47-Vitamin_D_Receptor-Mediated_Stromal_Reprogramming_Suppresses_Pancreatitis_and_Enhances_Pancriatic_Cancer_Therapy.pdf
Answered by mmoddey2 on January 14, 2015 at 4:25 pm